Aptus Pharma Ltd 52 Week Low
Aptus Pharma Ltd
NSE: APPL
YEARLOW
Key Highlights
- The 52 Week Low of Aptus Pharma Ltd is ₹ 32.32 as of 25 Sep 26 .
Company Fundamentals for Aptus Pharma Ltd
Market Price of Aptus Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 25 Sep 2026 | 347 |
| 24 Sep 2026 | 348 |
| 23 Sep 2026 | 354.1 |
| 22 Sep 2026 | 353.25 |
| 21 Sep 2026 | 360.45 |
| 18 Sep 2026 | 353.4 |
| 17 Sep 2026 | 346.5 |
| 16 Sep 2026 | 353.55 |
| 15 Sep 2026 | 346.65 |
| 11 Sep 2026 | 339.9 |
Asset Value vs Market Value of Aptus Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Aptus Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Aptus Pharma Ltd
Historical Net Profit of Aptus Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Aptus Pharma Ltd
Aptus Pharma Ltd News Hub
Shares of Aptus Pharma list in MT Group
The equity shares of Aptus Pharma (Scrip Code: 544529) are listed effective 30 September 2025 and ad
Read more
30 Sept 25
BSE SME Aptus Pharma cures listing-day jitters with premium opening
The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The
Read more
30 Sept 25
Aptus Pharma to raise Rs 44 cr for funding strategic growth and business expansion
Aptus Pharma has outlined its next phase of growth focused on developing its own manufacturing capab
Read more
24 Aug 26
Aptus Pharma schedules board meeting
Aptus Pharma will hold a meeting of the Board of Directors of the Company on 10 November 2025. Power
Read more
03 Nov 25
